Can I Take Turmeric or Curcumin with Lisinopril?

The direct answer

Turmeric used as a culinary spice does not appear to pose a meaningful interaction risk with lisinopril; the curcuminoid content of dietary turmeric is too low to produce a measurable pharmacological effect. Concentrated curcumin supplements are a different matter: several small human trials have reported modest blood-pressure reductions with curcumin, and separate small studies have reported mild antiplatelet activity. Neither effect has been tested in combination with lisinopril in a published trial, so the guidance below reflects pharmacological reasoning and general supplement safety practice rather than direct evidence for this pairing. Patients who want individualized dosing or timing advice should ask their prescriber or pharmacist rather than rely on this article alone.

Why this combination raises questions

Turmeric and curcumin supplements are widely used for joint pain, inflammation, and general wellness, and many people who take them are also on blood-pressure medication. The overlap is common, but it has not been studied directly as a drug-supplement pair.

Where the concern originates

Lisinopril lowers blood pressure by blocking the angiotensin-converting enzyme, reducing angiotensin II production and aldosterone-driven sodium retention. Curcumin has been studied in several small randomized trials for cardiometabolic effects, including modest reductions in blood pressure in some analyses, particularly with longer supplementation periods. The exact magnitude reported varies across studies and reviews, and a precise pooled effect size should be verified against the primary literature before being treated as a clinical certainty. The reasonable, non-alarmist takeaway is that curcumin's blood-pressure effect, if real, points in the same direction as lisinopril's mechanism, which is why an additive effect is biologically plausible.

Why patients often combine them

Many people with hypertension also manage joint pain, low-grade inflammation, or metabolic syndrome, conditions for which curcumin is commonly marketed. The practical question is not whether the combination is categorically dangerous, but which patients need closer monitoring and which do not.

Mechanism: what is established, what is plausible, what is not established

Pharmacodynamic overlap (plausible, not directly tested)

Curcumin has been proposed to promote endothelial nitric-oxide-mediated vasodilation, based on small human studies. If that effect is real and additive to ACE inhibition, the combined blood-pressure drop could exceed what either agent produces alone. This has not been tested directly in patients on lisinopril, so the size of any real-world additive effect is unknown. It is most likely to matter in people already prone to low blood pressure or orthostatic symptoms, such as older adults or those also taking a diuretic.

Pharmacokinetic pathway (established mechanism, low relevance for lisinopril)

Curcumin has shown CYP3A4 and CYP2C9 inhibition in laboratory (in vitro) studies. This matters for drugs that rely on hepatic metabolism. Lisinopril is not metabolized by the liver to a meaningful degree; it is excreted largely unchanged by the kidneys, per its FDA prescribing information. Because of this, curcumin's enzyme-inhibiting activity is unlikely to meaningfully change lisinopril blood levels. The same reasoning does not automatically apply to other ACE inhibitors that are hepatically metabolized (such as enalapril or ramipril), so this specific reassurance should not be generalized across the ACE inhibitor class.

Antiplatelet and bleeding risk (established for curcumin alone, relevant mainly with a third agent)

Small human and laboratory studies have reported that curcumin can reduce platelet aggregation. Lisinopril itself has no antiplatelet or anticoagulant activity. The bleeding-risk concern becomes practically relevant when a patient is taking lisinopril alongside a separate anticoagulant (warfarin, apixaban, rivaroxaban, or similar) and then adds curcumin as a third agent, rather than from the lisinopril-curcumin pair alone.

Piperine (BioPerine) as a confound

Many curcumin products are formulated with piperine (black pepper extract) to increase absorption. This combination has been studied and piperine is well documented to substantially increase curcumin bioavailability. Piperine separately inhibits CYP3A4 and P-glycoprotein, which does not change lisinopril's renal clearance but can affect other medications a patient is taking. Patients on multiple prescription drugs should mention piperine-containing supplements to their pharmacist specifically, not just the turmeric or curcumin content.

Evidence-status interaction assessment

What a clinician or pharmacist should verify before advising a specific patient: current antihypertensive regimen and doses, kidney function (eGFR), concurrent anticoagulant or antiplatelet use, the exact curcumin product and whether it contains piperine, and any history of orthostatic hypotension or falls.

Risk stratification: who needs more caution

Lower-risk profile

Adults under 65, on lisinopril alone with no other antihypertensive, with normal kidney function, taking a standard-dose curcumin supplement (roughly 500 mg or less of standardized extract daily), and not on any anticoagulant. Basic monitoring is reasonable for this group.

Higher-risk profile

Adults over 75, those on multiple antihypertensive drugs, reduced kidney function, concurrent anticoagulant use, or a history of falls or fainting. These patients should discuss curcumin supplementation with a prescriber before starting, and may need closer blood-pressure and kidney-function follow-up.

Practical steps for taking both

Timing

Separating curcumin and lisinopril doses by a few hours is a reasonable, low-cost precaution to reduce the chance of overlapping peak effects, even though the exact pharmacokinetic timing of curcumin relative to lisinopril has not been studied together. Taking one in the morning and the other in the evening is a simple approach.

Dose awareness

Standardized curcumin supplements are typically sold in doses from 500 mg to 2,000 mg of curcuminoids. Higher doses have more plausible pharmacological effect and therefore more theoretical interaction potential. Starting at the lowest available dose when adding curcumin to a stable lisinopril regimen, and monitoring for two weeks, is a reasonable approach. This is general guidance, not an individualized dosing recommendation; specific dosing decisions should go through a prescriber or pharmacist.

What to avoid

Avoid starting a high-dose curcumin supplement and a new blood-pressure medication at the same time, since it becomes difficult to tell which agent is responsible for any symptoms. Avoid combining curcumin with lisinopril and a separate anticoagulant without prescriber input. Do not use this article to determine dosing for a specific medical situation.

Monitoring

Blood pressure

Home blood-pressure monitoring with a validated upper-arm cuff is a standard recommendation from major hypertension guidelines for anyone on antihypertensive therapy. When adding curcumin to lisinopril, checking blood pressure at home for the first one to two weeks is a reasonable precaution. A systolic reading consistently below 100 mmHg, or symptomatic dizziness on standing, should prompt a call to the prescriber and reconsideration of the curcumin dose. A systolic reading below 90 mmHg, or fainting, warrants urgent medical contact.

Kidney function

Lisinopril can raise serum creatinine as an expected pharmacological effect of ACE inhibition, and this is already monitored as part of routine ACE-inhibitor care. There is no strong clinical evidence that standard-dose curcumin worsens kidney function, but patients with pre-existing chronic kidney disease should have this checked as part of their normal ACE-inhibitor monitoring, not because curcumin specifically requires new lab work.

Bleeding

No routine lab test is needed for curcumin and lisinopril alone. Patients should watch for unusual bruising, prolonged bleeding from minor cuts, nosebleeds, or blood in stool, and report these to their prescriber. Anyone on warfarin or another anticoagulant who adds curcumin should discuss additional monitoring, such as an INR check, with the prescriber managing that anticoagulant.

What the evidence actually shows, and what it does not

No published clinical trial of curcumin combined specifically with lisinopril was identified. The safety picture here is built from separate lines of evidence: general pharmacology of ACE inhibitors, small human trials of curcumin's cardiovascular effects, laboratory studies of curcumin's enzyme and platelet effects, and general supplement safety practice. Extrapolating from these separate literatures to a specific combined drug-supplement pair carries real uncertainty, and readers should treat any precise numeric claim about "how much" blood pressure will drop, or "how much" bleeding risk increases, with caution unless it comes from a trial studying the actual combination. As of this review (May 2026), no such combination trial has been identified, and general supplement interaction databases classify the turmeric-ACE inhibitor interaction as a moderate, plausibility-based concern rather than one based on documented case reports of serious harm.

If you are already taking both

If you have been taking curcumin and lisinopril together without symptoms, that is reassuring but does not eliminate the value of a baseline check. Checking blood pressure at home for a few consecutive days, reviewing the curcumin product label for piperine content and total curcuminoid dose, and bringing the supplement bottle to your next appointment are reasonable steps. If blood pressure readings run consistently low or you notice dizziness, reducing the curcumin dose and rechecking, or discussing it with your prescriber, is appropriate before making any change to lisinopril itself.

When to seek care

Stop the curcumin supplement and contact your prescriber if you experience fainting, unexplained significant bruising, a systolic blood pressure below 90 mmHg, or new swelling that concerns you. These could reflect an interaction or an unrelated problem that needs clinical evaluation, and self-diagnosis is not a substitute for that evaluation.

Special situations

Diabetes

Lisinopril is commonly prescribed in type 2 diabetes for kidney protection. Some small trials have reported modest glucose-lowering effects with curcumin. Patients on insulin or sulfonylureas who add curcumin should be aware of the possibility of low blood sugar in addition to watching for low blood pressure, and should discuss this with the clinician managing their diabetes.

Diuretics

Many patients take lisinopril together with a thiazide diuretic such as hydrochlorothiazide. Adding curcumin to this pairing increases the number of agents that could plausibly affect blood pressure or fluid balance at once, which is a reason for closer monitoring rather than a reason to avoid the combination outright.

Before surgery

Because curcumin has shown antiplatelet activity in small studies, general perioperative guidance for herbal supplements with antiplatelet or anticoagulant properties is to stop them roughly two weeks before elective surgery, while continuing prescribed medications like lisinopril according to the surgical team's instructions. Confirm the exact timing with the surgical or anesthesia team rather than assuming a fixed rule applies to every procedure.